Patrick J. O’Hearn

1.3k total citations
2 papers, 18 citations indexed

About

Patrick J. O’Hearn is a scholar working on Molecular Biology, Cancer Research and Infectious Diseases. According to data from OpenAlex, Patrick J. O’Hearn has authored 2 papers receiving a total of 18 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cancer Research and 0 papers in Infectious Diseases. Recurrent topics in Patrick J. O’Hearn's work include Cancer, Lipids, and Metabolism (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Cancer Genomics and Diagnostics (1 paper). Patrick J. O’Hearn is often cited by papers focused on Cancer, Lipids, and Metabolism (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Cancer Genomics and Diagnostics (1 paper). Patrick J. O’Hearn collaborates with scholars based in United States. Patrick J. O’Hearn's co-authors include James Watters, Dejan Maglic, Jessica B. Casaletto, Roberto Valverde, Lindsey Foster, Demetri T. Moustakas, Donald A. Bergstrom, Dina A. Sharon, Alex Taylor and B. Barry Touré and has published in prestigious journals such as Cancer Research.

In The Last Decade

Patrick J. O’Hearn

2 papers receiving 17 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick J. O’Hearn United States 2 13 6 5 5 2 2 18
Elizabeth Reilly United States 3 18 1.4× 8 1.3× 4 0.8× 7 1.4× 2 1.0× 4 33
Ellice Marwood United Kingdom 2 12 0.9× 6 1.0× 9 1.8× 5 1.0× 4 2.0× 2 19
Nils Rouven Hansmeier Germany 4 9 0.7× 7 1.2× 3 0.6× 8 1.6× 3 1.5× 5 27
Danielle Pasternack Canada 2 13 1.0× 3 0.5× 3 0.6× 4 0.8× 3 1.5× 2 20
Laura delaCruz‐Villar Italy 2 10 0.8× 7 1.2× 5 1.0× 2 0.4× 1 0.5× 4 32
Olawale Badejo Nigeria 4 8 0.6× 7 1.2× 8 1.6× 11 2.2× 2 1.0× 7 28
Francesca Rocchetti United States 2 11 0.8× 7 1.2× 4 0.8× 2 0.4× 2 1.0× 3 19
Mark P.G. Dings Netherlands 2 12 0.9× 8 1.3× 2 0.4× 8 1.6× 3 1.5× 3 16
Yanjuan Ma China 3 13 1.0× 3 0.5× 3 0.6× 3 0.6× 3 1.5× 3 18
Catherine Tolman United States 2 12 0.9× 8 1.3× 2 0.4× 3 0.6× 2 1.0× 2 23

Countries citing papers authored by Patrick J. O’Hearn

Since Specialization
Citations

This map shows the geographic impact of Patrick J. O’Hearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. O’Hearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. O’Hearn more than expected).

Fields of papers citing papers by Patrick J. O’Hearn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. O’Hearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. O’Hearn. The network helps show where Patrick J. O’Hearn may publish in the future.

Co-authorship network of co-authors of Patrick J. O’Hearn

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. O’Hearn. A scholar is included among the top collaborators of Patrick J. O’Hearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. O’Hearn. Patrick J. O’Hearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Casaletto, Jessica B., Dejan Maglic, B. Barry Touré, et al.. (2021). Abstract 1455: RLY-4008, a novel precision therapy for FGFR2-driven cancers designed to potently and selectively inhibit FGFR2 and FGFR2 resistance mutations. Cancer Research. 81(13_Supplement). 1455–1455. 13 indexed citations
2.
Brophy, Erin, James Conley, Patrick J. O’Hearn, et al.. (2013). Abstract 1891: Pharmacological target validation studies of fatty acid synthase in carcinoma using the potent, selective and orally bioavailable inhibitor IPI-9119.. Cancer Research. 73(8_Supplement). 1891–1891. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Reilly Breakdown of academic impact, for papers by Ellice Marwood Breakdown of academic impact, for papers by Nils Rouven Hansmeier Breakdown of academic impact, for papers by Danielle Pasternack Breakdown of academic impact, for papers by Laura delaCruz‐Villar Breakdown of academic impact, for papers by Olawale Badejo Breakdown of academic impact, for papers by Francesca Rocchetti Breakdown of academic impact, for papers by Mark P.G. Dings Breakdown of academic impact, for papers by Yanjuan Ma Breakdown of academic impact, for papers by Catherine Tolman
Rankless by CCL
2026